It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Paget’s disease of bone (PDB) is characterised by focal abnormalities of bone remodelling, with increased osteoclastic resorption the primary feature of the disease. Genetic factors have been shown to play an important role in PDB, and genome-wide association studies (GWAS) have identified 7 genetic loci as associated with PDB at the genome-wide level. Expression quantitative trait locus (eQTL) studies using cell types that are directly relevant to the disease of interest are increasingly being used to identify putative effector genes for GWAS loci. We have recently constructed a unique osteoclast-specific eQTL resource using cells differentiated in vitro from 158 subjects for study of the genetics of bone disease. Considering the major role osteoclasts have in PDB, we used this resource to investigate potential genetic regulatory effects for the 7 PDB genome-wide significant loci on genes located within 500 kb of each locus. After correction for multiple testing, we observed statistically significant associations for rs4294134 with expression of the gene STMP1, and rs2458413 with expression of the genes DPYS and DCSTAMP. The eQTL associations observed for rs4294134 with STMP1, and rs2458413 with DCSTAMP were further supported by eQTL data from other tissue types. The product of the STMP1 gene has not been extensively studied, however the DCSTAMP gene has an established role in osteoclast differentiation and the associations seen between rs2458413 and PDB are likely mediated through regulatory effects on this gene. This study highlights the value of eQTL data in determining which genes are relevant to GWAS loci.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Sir Charles Gairdner Hospital, Department of Endocrinology & Diabetes, Nedlands, Australia (GRID:grid.3521.5) (ISNI:0000 0004 0437 5942); University of Western Australia, School of Biomedical Sciences, Crawley, Australia (GRID:grid.1012.2) (ISNI:0000 0004 1936 7910)
2 Sir Charles Gairdner Hospital, Department of Endocrinology & Diabetes, Nedlands, Australia (GRID:grid.3521.5) (ISNI:0000 0004 0437 5942); University of Western Australia, Medical School, Crawley, Australia (GRID:grid.1012.2) (ISNI:0000 0004 1936 7910)
3 Sir Charles Gairdner Hospital, Department of Endocrinology & Diabetes, Nedlands, Australia (GRID:grid.3521.5) (ISNI:0000 0004 0437 5942)
4 University of Western Australia, School of Biomedical Sciences, Crawley, Australia (GRID:grid.1012.2) (ISNI:0000 0004 1936 7910)
5 University of Leicester, Department of Health Sciences, Leicester, UK (GRID:grid.9918.9) (ISNI:0000 0004 1936 8411)
6 Sir Charles Gairdner Hospital, Department of Endocrinology & Diabetes, Nedlands, Australia (GRID:grid.3521.5) (ISNI:0000 0004 0437 5942); University of Western Australia, School of Biomedical Sciences, Crawley, Australia (GRID:grid.1012.2) (ISNI:0000 0004 1936 7910); King’s College London, Department of Twin Research & Genetic Epidemiology, London, UK (GRID:grid.13097.3c) (ISNI:0000 0001 2322 6764)